Pharma BD Deal Intelligence
Bristol-Myers Squibb Company / Adnexus Therapeutics Inc.
2007 · Acquisition/Merger · $430M · Complete
Announcement Sentiment
75
Strongly positive
$430M cash + up to $75M earnout. Adnectins biologics platform; Angiocept Phase I. Source: SEC, Fierce Biotech, WilmerHale.
Key facts
- Announced Sep 24, 2007
- Deal value $430M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals